Please login to the form below

Not currently logged in
Email:
Password:

immunotherapies

This page shows the latest immunotherapies news and features for those working in and with pharma, biotech and healthcare.

Merck’s Keytruda meets survival challenge in NSCLC

Merck’s Keytruda meets survival challenge in NSCLC

Merck &Co’s grip on the first-line non-small cell lung cancer (NSCLC) immunotherapy market seems set to tighten, after its PD-1 inhibitor Keytruda halved the risk of death ... The company is now preparing to file the data with regulators around with

Latest news

More from news
Approximately 57 fully matching, plus 314 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Back in June 2015 Celgene and Juno announced a ten-year collaboration to combine their respective immunology expertise to develop new immunotherapies for cancer and autoimmune diseases based on T cell

  • The good, the bad and the ugly The good, the bad and the ugly

    2018 looks set to be an interesting year - coloured by the prospect of M&A, patent expiry and pricing challenges, but also invigorated by exciting advances in immunotherapy and oncology and

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

  • Deal Watch March 2017 Deal Watch March 2017

    BioLineRx. Acquisition. Portfolio, including AGI-134, synthetic alpha-GaI immunotherapy for solid tumours.

More from intelligence
Approximately 0 fully matching, plus 39 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics